Business Description
Cochlear Ltd
ISIN : US1914592050
Share Class Description:
FRA:OC50: ADRTotal Employee Number:
5,500Description
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.43 | |||||
Interest Coverage | 33.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.78 | |||||
Beneish M-Score | -2.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.6 | |||||
3-Year EBITDA Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 10.6 | |||||
3-Year FCF Growth Rate | -23.2 | |||||
3-Year Book Growth Rate | 5.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.16 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 69.02 | |||||
9-Day RSI | 71.4 | |||||
14-Day RSI | 66.53 | |||||
3-1 Month Momentum % | -42.31 | |||||
6-1 Month Momentum % | -58.9 | |||||
12-1 Month Momentum % | -64.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.46 | |||||
Quick Ratio | 1.44 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 291.63 | |||||
Days Sales Outstanding | 82.47 | |||||
Days Payable | 165.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.41 | |||||
Dividend Payout Ratio | 0.81 | |||||
3-Year Dividend Growth Rate | 12.9 | |||||
Forward Dividend Yield % | 3.41 | |||||
5-Year Yield-on-Cost % | 10.7 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.63 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.77 | |||||
Operating Margin % | 16.43 | |||||
Net Margin % | 14.77 | |||||
EBITDA Margin % | 24.17 | |||||
FCF Margin % | 7.08 | |||||
OCF Margin % | 11.31 | |||||
ROE % | 18 | |||||
ROA % | 12.33 | |||||
ROIC % | 13.06 | |||||
3-Year ROIIC % | 13.49 | |||||
ROC (Joel Greenblatt) % | 43.11 | |||||
ROCE % | 21.17 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 23.69 | |||||
Forward PE Ratio | 22.04 | |||||
PE Ratio without NRI | 23.69 | |||||
Shiller PE Ratio | 29.21 | |||||
Price-to-Owner-Earnings | 18.5 | |||||
PS Ratio | 3.5 | |||||
PB Ratio | 4.22 | |||||
Price-to-Tangible-Book | 5.71 | |||||
Price-to-Free-Cash-Flow | 49.45 | |||||
Price-to-Operating-Cash-Flow | 30.94 | |||||
EV-to-EBIT | 17.62 | |||||
EV-to-Forward-EBIT | 39.48 | |||||
EV-to-EBITDA | 14.56 | |||||
EV-to-Forward-EBITDA | 13.62 | |||||
EV-to-Revenue | 3.52 | |||||
EV-to-Forward-Revenue | 3.43 | |||||
EV-to-FCF | 49.71 | |||||
Price-to-GF-Value | 0.4 | |||||
Price-to-Projected-FCF | 2.54 | |||||
Price-to-Median-PS-Value | 0.41 | |||||
Price-to-Graham-Number | 2.45 | |||||
| Price-to-Net-Current-Asset-Value | 15.83 | |||||
Earnings Yield (Greenblatt) % | 5.68 | |||||
FCF Yield % | 2.03 | |||||
Forward Rate of Return (Yacktman) % | 22.24 |
Cochlear Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cochlear Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-10-23 10:00 | In 110 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-14 10:00 | In 40 days | ||
| Annual report for 2026 | 2026-08-14 | In 39 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-14 | In 39 days | ||
| USD 0.759595 Cash Dividend | 2026-03-20 | 52.00 (+0.00%) | ||
| Second quarter earnings conference call for 2026 | 2026-02-13 10:00 | 75.50 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-02-13 | 75.50 (+0.00%) | ||
| General meeting for 2025 | 2025-10-23 10:00 | 80.50 (+0.00%) | ||
| USD 0.691332 Cash Dividend | 2025-09-19 | 85.00 (+1.19%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-08-15 10:00 | 86.00 (+0.00%) |
Show
Entries
Press Release
Articles on Cochlear Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers